This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $1,800,000
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
CIHR · 2021 · Principal investigator
- $10,000
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
CIHR · 2020 · Principal investigator
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
Principal investigators: Dubé, Marie-Pierre; Carpentier, André C; Lewis, Gary F; Tardif, Jean-Claude
Keywords: Colchicine; Diabetes; Gender; Genomics; Pharmacogenomics; Proteomics
Precision medicine study of type 2 diabetes in the COLCOT-T2D trial
Principal investigators: Dubé, Marie-Pierre; Carpentier, André C; Lewis, Gary F; Tardif, Jean-Claude
Keywords: Clinical Trial; Colchicine; Drug Concentrations; Drug Metabolites; Genomics; Gwas; Pharmacogenomics; Precision Medicine; Proteomics; Type 2 Diabetes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.